Clinical Trial Details

Trial ID: L0430
Source ID: EUCTR2020-000220-19-AT
Associated Drug: Liraglutide
Title: Comparing effects of weight loss by Liraglutide 3.0 mg with conventional liver fasting in non-alcoholic fatty liver disease before bariatric surgery - Weight loss under Liraglutide 3.0mg
Acronym: --
Status: Authorised
Study Results: No Results Available
Results: --
Conditions: Obesity and NAFLD can increase the risk and complexity of bariatric surgery up to 20%. Reducing the weight and liver size before bariatric surgery improves the operation area and reduces complications after the procedure.;Therapeutic area: Body processes
Interventions: <br>Trade Name: Saxenda<br>Pharmaceutical Form: Solution for injection<br>INN or Proposed INN: LIRAGLUTIDE<br>CAS Number: 204656-20-2<br>Concentration unit: mg/ml milligram(s)/millilitre<br>Concentration type: equal<br>Concentration number: 6-<br><br>
Outcome Measures: Main Objective: weight loss before bariatric surgery ;Secondary Objective: liver size reduction;Primary end point(s): weight loss before bariatric surgery ;Timepoint(s) of evaluation of this end point: after 12 weeks Secondary end point(s): liver size reduction;Timepoint(s) of evaluation of this end point: after 12 weeks
Sponsor/Collaborators: Verein zur F??rderung von Wissenschaft und Forschung an der 1. Med. Abteilung der Krankenanstalt Rudolfstiftung
Gender: All
Age: nannan
Phases: Phase 4
Enrollment: 62
Study Type: Interventional clinical trial of medicinal product
Study Designs: Controlled: no<br>Randomised: yes<br>Open: yes<br>Single blind: no<br>Double blind: no<br>Parallel group: yes<br>Cross over: no<br>Other: no<br>If controlled, specify comparator, Other Medicinial Product: no<br>Placebo: no<br>Other: yes<br>Other specify t
Start Date: 24/03/2020
Completion Date: --
Results First Posted: --
Last Update Posted: 7 December 2020
Locations: Austria
URL: https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-000220-19